Evidence map›Paper›PMID 41169378›Full record

ReviewFrontiers in immunology2025

Significance of circular RNAs in regulating protein ubiquitination for malignant tumor progression.

Haidong Zhong, Wei Li, Peiyue Luo, Qi Chen, Le Cheng, Lifeng Gan, Fangtao Zhang, Yiran Lu, Liying Zheng, Biao Qian

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haidong ZhongThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Wei LiThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Peiyue LuoThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Qi ChenThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Le ChengThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Lifeng GanThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Fangtao ZhangThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Yiran LuThe First Clinical College, Gannan Medical University, Ganzhou, Jiangxi, China.
Liying ZhengDepartment of Graduate, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Biao QianDepartment of Urology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CircRNAs are an important class of non-coding RNAs, which are produced via back-splicing of exons and/or intron sequences of precursor mRNAs and generally cannot be translated into proteins as they do not bind to ribosomes. There is varying evidence supporting the claim that circRNAs are abnormally expressed in cancer and play a crucial role in cancer initiation and progression. Ubiquitin is a highly stable protein that can be conjugated to target proteins. The most crucial role of ubiquitination is to mediate the degradation of substrate proteins by the proteasome. An increasing amount of evidence indicates that circRNAs are involved in the precise degradation of proteins via the ubiquitin-proteasome system. This review systematically summarizes the intricate mechanisms by which circRNAs regulate target protein ubiquitination, modulate cancerous signaling pathways, and control tumorigenesis and tumor development. Although studies are continuously uncovering additional complex interactions between circRNAs and proteins, we believe that circRNAs are promising but challenging molecules that have the potential to facilitate precise cancer therapies in the future.

Indexed as

NeoplasmsRNA, CircularUbiquitinationAnimalsDisease ProgressionGene Expression Regulation, NeoplasticHumansSignal TransductionUbiquitinRNA, CircularUbiquitincancer therapycircRNAimmunotherapymalignant tumorubiquitination

Identifiers

PMID41169378
PMCPMC12568580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.